BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 35361152)

  • 1. Clinicopathological characteristics, survival outcomes and prognostic factors in pleomorphic carcinoma: a SEER population-based study.
    Chen Z; Liu J; Min L
    BMC Pulm Med; 2022 Mar; 22(1):116. PubMed ID: 35361152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological characteristics and prognosis of pulmonary pleomorphic carcinoma: a population-based retrospective study using SEER data.
    Yin J; Yang Y; Ma K; Yang X; Lu T; Wang S; Shi Y; Zhan C; Zhu Y; Wang Q
    J Thorac Dis; 2018 Jul; 10(7):4262-4273. PubMed ID: 30174872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and prognosis of pulmonary large cell carcinoma: A population-based retrospective study using SEER data.
    Xiaochuan L; Jiangyong Y; Ping Z; Xiaonan W; Lin L
    Thorac Cancer; 2020 Jun; 11(6):1522-1532. PubMed ID: 32301286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological characteristics and prognosis of uterine serous carcinoma: A SEER program analysis of 1016 cases.
    Han Y; Liu C
    J Obstet Gynaecol Res; 2021 Jul; 47(7):2460-2472. PubMed ID: 33870589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
    Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
    World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of Site-Specific Metastases and Therapeutic Roles of Surgery and Chemotherapy for Patients With Metastatic Renal Pelvis Cancer: A SEER Based Study.
    Chen WK; Wu ZG; Xiao YB; Wang QQ; Yu DD; Cai J; Zhou CF
    Technol Cancer Res Treat; 2021; 20():15330338211004914. PubMed ID: 33929915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy improves the prognosis of early stage resectable pulmonary large cell carcinoma: analysis of SEER data.
    Hu X; Tai Q; Su B; Zhang L
    Ann Palliat Med; 2020 Mar; 9(2):199-206. PubMed ID: 32156139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database.
    Ding J; Wen Z
    BMC Cancer; 2021 Oct; 21(1):1157. PubMed ID: 34715816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary pulmonary leiomyosarcoma: A population-based study.
    Qin BD; Jiao XD; Zang YS
    Lung Cancer; 2018 Feb; 116():67-72. PubMed ID: 29413053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological characteristics and survival outcomes in neuroendocrine prostate cancer: A population-based study.
    Zhu J; Liang X; Wu D; Chen S; Yang B; Mao W; Shen D
    Medicine (Baltimore); 2021 Apr; 100(15):e25237. PubMed ID: 33847621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological characteristics, treatment and survival of pulmonary large cell neuroendocrine carcinoma: a SEER population-based study.
    Cao L; Li ZW; Wang M; Zhang TT; Bao B; Liu YP
    PeerJ; 2019; 7():e6539. PubMed ID: 30944773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and treatments of large cell lung carcinoma: a retrospective study using SEER data.
    Tai Q; Zhang L; Hu X
    Transl Cancer Res; 2020 Mar; 9(3):1455-1464. PubMed ID: 35117493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of prognostic factors for survival in patients with primary spinal chordoma using the SEER Registry from 1973 to 2014.
    Pan Y; Lu L; Chen J; Zhong Y; Dai Z
    J Orthop Surg Res; 2018 Apr; 13(1):76. PubMed ID: 29625617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival and prognostic factors for postoperative primary appendiceal cancer: a retrospective cohort study based on the Surveillance, Epidemiology, and End Results database.
    Wang Y; Geng Y; Hu W
    J Gastrointest Oncol; 2022 Jun; 13(3):1433-1443. PubMed ID: 35837159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of a Competing Risk Nomogram in Patients with Pulmonary Sarcomatoid Carcinoma.
    Liang Z; Zhang E; Duan L; Weygant N; An G; Hu B; Yao J
    Technol Cancer Res Treat; 2022; 21():15330338211068960. PubMed ID: 35179409
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinicopathological characteristics and cancer-specific prognosis of primary pulmonary lymphoepithelioma-like carcinoma: a population study of the US SEER database and a Chinese hospital.
    Zhang Q; Dai Y; Jin L; Shi S; Liu C; Rong R; Sun W; Dai S; Kong H; Xie W
    Front Oncol; 2023; 13():1103169. PubMed ID: 37274245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and prognosis of lymphoepithelioma-like carcinoma: a comprehensive analysis of surveillance, epidemiology, and end results (SEER) database.
    Qi WX; Zhao S; Chen J
    Int J Clin Oncol; 2021 Jul; 26(7):1203-1211. PubMed ID: 33844112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of surgery on survival in patients with stage III N2 small cell lung cancer: propensity score matching analysis and nomogram development and validation.
    Chai Y; Ma Y; Feng W; Lu H; Jin L
    World J Surg Oncol; 2021 Aug; 19(1):258. PubMed ID: 34461929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological characteristics and prognostic factors of pulmonary large cell neuroendocrine carcinoma: A large population-based analysis.
    Yang Q; Xu Z; Chen X; Zheng L; Yu Y; Zhao X; Chen M; Luo B; Wang J; Sun J
    Thorac Cancer; 2019 Apr; 10(4):751-760. PubMed ID: 30734490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Clinical Characteristics and Treatments for Large Cell Carcinoma Patients Older than 65 Years Old: A Population-Based Study.
    Yao A; Liang L; Rao H; Shen Y; Wang C; Xie S
    Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.